Janina Jamasbi

510 total citations
12 papers, 387 citations indexed

About

Janina Jamasbi is a scholar working on Hematology, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Janina Jamasbi has authored 12 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Internal Medicine and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Janina Jamasbi's work include Platelet Disorders and Treatments (9 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Blood properties and coagulation (4 papers). Janina Jamasbi is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Venous Thromboembolism Diagnosis and Management (5 papers) and Blood properties and coagulation (4 papers). Janina Jamasbi collaborates with scholars based in Germany, Netherlands and Israel. Janina Jamasbi's co-authors include Wolfgang Siess, Reinhard Lorenz, Christian Weber, Richard Brandl, Remco T. A. Megens, Bernhard Nieswandt, Martin Ungerer, Götz Münch, Shinya Goto and Karlheinz Peter and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Janina Jamasbi

12 papers receiving 384 citations

Peers

Janina Jamasbi
Josephine P. Ferrel United States
Melanie McCabe White United States
J Winckler France
UM Marzec United States
Kiat Tsong Tan United Kingdom
Zhong-Fu Huang United States
Janina Jamasbi
Citations per year, relative to Janina Jamasbi Janina Jamasbi (= 1×) peers Lidia Usnarska‐Zubkiewicz

Countries citing papers authored by Janina Jamasbi

Since Specialization
Citations

This map shows the geographic impact of Janina Jamasbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janina Jamasbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janina Jamasbi more than expected).

Fields of papers citing papers by Janina Jamasbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janina Jamasbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janina Jamasbi. The network helps show where Janina Jamasbi may publish in the future.

Co-authorship network of co-authors of Janina Jamasbi

This figure shows the co-authorship network connecting the top 25 collaborators of Janina Jamasbi. A scholar is included among the top collaborators of Janina Jamasbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janina Jamasbi. Janina Jamasbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Zhang, Danmei, Kristin Adler, Xavier Blanchet, et al.. (2020). Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood. Thrombosis and Haemostasis. 120(6). 977–993. 10 indexed citations
2.
Jamasbi, Janina, et al.. (2019). Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib. Thrombosis and Haemostasis. 119(3). 397–406. 27 indexed citations
3.
Jamasbi, Janina, Kristin Adler, Remco T. A. Megens, et al.. (2018). Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin. Thrombosis and Haemostasis. 118(2). 351–361. 22 indexed citations
4.
Jamasbi, Janina, Till Seiler, Hans Deckmyn, et al.. (2018). Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans. Blood. 131(24). 2605–2616. 69 indexed citations
5.
Jamasbi, Janina, Kerstin Uhland, Götz Münch, et al.. (2017). Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation. Thrombosis and Haemostasis. 117(8). 1651–1659. 25 indexed citations
6.
Jamasbi, Janina, et al.. (2017). Platelet receptors as therapeutic targets: Past, present and future. Thrombosis and Haemostasis. 117(7). 1249–1257. 61 indexed citations
7.
Borst, Oliver, M. Ziégler, Janina Jamasbi, et al.. (2017). ADPase CD39 Fused to Glycoprotein VI‐Fc Boosts Local Antithrombotic Effects at Vascular Lesions. Journal of the American Heart Association. 6(8). 20 indexed citations
8.
Ortega‐Gómez, Almudena, Melanie Salvermoser, Jan Rossaint, et al.. (2016). Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment. Circulation. 134(16). 1176–1188. 58 indexed citations
9.
Jamasbi, Janina, Remco T. A. Megens, Mariaelvy Bianchini, et al.. (2016). Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation. JACC Basic to Translational Science. 1(3). 131–142. 19 indexed citations
10.
Petzold, Tobias, Manuela Thienel, Ildiko Konrad, et al.. (2016). Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis. Science Translational Medicine. 8(367). 367ra168–367ra168. 27 indexed citations
11.
Jamasbi, Janina, Remco T. A. Megens, Mariaelvy Bianchini, et al.. (2015). Differential Inhibition of Human Atherosclerotic Plaque–Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies. Journal of the American College of Cardiology. 65(22). 2404–2415. 40 indexed citations
12.
Zipse, Hendrik, Wolfgang Siess, Andreas Schmidt, et al.. (2013). Stereo specific platelet inhibition by the natural LXR agonist 22(R)-OH-cholesterol and its fluorescence labelling with preserved bioactivity and chiral handling in macrophages. Biochemical Pharmacology. 86(2). 279–285. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026